RE: Media statement from new CEO Phil in scrip16 Jan 2025 10:35
‘ There's certainly enough data on Scib ...and promising early data on Moditope ...to grab the attention of a major pharma , and then we have the mAbs pipeline’
Agreed, 2 deals done with Genmab and current trial(s) results far exceeding the current standard of care !
They will all have to sit up and take notice very soon if the results keep up the pace in the next few months.